RC
Roth Capital Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
176
Sunrun
RUN
$3.9B
|
PS
Philip Shen
| $16.92 | $30 |
77%
upside
| Buy |
20 Jul ‘22
3 years ago |
|
177
The ONE Group
STKS
$84.2M
|
GK
George Kelly
| $2.72 | $13 |
378%
upside
| Buy |
19 Jul ‘22
3 years ago |
|
178
Tilray
TLRY
$1.23B
|
SF
Scott Fortune
| $1.12 | $4 |
257%
upside
| Neutral |
15 Jul ‘22
3 years ago |
|
179
MGP Ingredients
MGPI
$605M
|
SM
Sean McGowan
| $28.39 | $115 |
305%
upside
| Buy |
30 Jun ‘22
3 years ago |
|
180
Biote Corp
BTMD
$109M
|
GK
George Kelly
| $3.45 | $9 |
161%
upside
| Buy |
23 Jun ‘22
3 years ago |
|
|
FPI
181
Farmland Partners
FPI
$471M
|
GS
Gerry Sweeney
| $10.66 | $16 |
50%
upside
| Buy |
21 Jun ‘22
3 years ago |
|
182
GH Research
GHRS
$838M
|
EP
Elemer Piros
| $13.51 | $66 |
389%
upside
| Buy |
16 Jun ‘22
3 years ago |
|
183
Ocugen
OCGN
$322M
|
JA
Jonathan Aschoff
| $1.03 | $8 |
677%
upside
| Buy |
15 Jun ‘22
3 years ago |
|
184
Valmont Industries
VMI
$7.49B
|
BW
Brian Wright
| $379.57 | $297 |
22%
downside
| Buy |
3 Jun ‘22
3 years ago |
|
185
Lindsay Corp
LNN
$1.52B
| $140.39 | $135 |
4%
downside
| Neutral |
3 Jun ‘22
3 years ago |
|
|
|
ENTO
186
Entero Therapeutics
ENTO
$4.18M
|
JA
Jonathan Aschoff
| $2.63 | $264,600 |
10,060,737%
upside
| Buy |
26 May ‘22
3 years ago |
|
187
Salesforce
CRM
$240B
|
RB
Richard Baldry
| $252.27 | $242 |
4%
downside
| Buy |
18 May ‘22
3 years ago |
|
188
Enanta Pharmaceuticals
ENTA
$190M
|
ZJ
Zegbeh Jallah
| $8.91 | $70 |
686%
upside
| Buy |
12 May ‘22
3 years ago |
|
189
Array Technologies
ARRY
$1.34B
|
PS
Philip Shen
| $8.75 | $7 |
20%
downside
| Neutral |
11 May ‘22
3 years ago |
|
190
LivePerson
LPSN
$93.7M
|
RB
Richard Baldry
| $0.9700 | $25 |
2,477%
upside
| Buy |
10 May ‘22
3 years ago |
|
191
fuboTV
FUBO
$1.41B
|
DA
Darren Aftahi
| $4.12 | $4.25 |
3%
upside
| Neutral |
6 May ‘22
3 years ago |
|
192
OptimizeRx
OPRX
$340M
|
RB
Richard Baldry
| $18.29 | $66 |
261%
upside
| Buy |
5 May ‘22
3 years ago |
|
193
MindMed
MNMD
$714M
|
EP
Elemer Piros
| $9.39 | $105 |
1,018%
upside
| Buy |
4 May ‘22
3 years ago |
|
194
Apellis Pharmaceuticals
APLS
$3.4B
|
EP
Elemer Piros
| $26.91 | $40 |
49%
upside
| Sell |
14 Apr ‘22
3 years ago |
|
|
IVF
195
INVO Fertility, Inc. Common Stock
IVF
$4.41M
|
SH
Scott Henry
| $1.01 | $40 |
3,860%
upside
| Neutral |
13 Apr ‘22
3 years ago |
|
196
Direct Digital Holdings
DRCT
$9.57M
|
DA
Darren Aftahi
| $0.4250 | $4 |
841%
upside
| Buy |
28 Mar ‘22
3 years ago |
|
197
Hudson Technologies
HDSN
$450M
|
GS
Gerry Sweeney
| $10.31 | $6.50 |
37%
downside
| Buy |
9 Mar ‘22
3 years ago |
|
|
XXII
198
22nd Century Group
XXII
$6.13M
|
BW
Brian Wright
| $1.62 | $4,471,200 |
275,999,900%
upside
| Buy |
8 Mar ‘22
3 years ago |
|
199
GrowGeneration
GRWG
$92M
|
SF
Scott Fortune
| $1.54 | $8 |
419%
upside
| Neutral |
3 Mar ‘22
3 years ago |
|
200
Purple Innovation
PRPL
$118M
|
MK
Matt Koranda
| $1.09 | $6 |
450%
upside
| Neutral |
2 Mar ‘22
3 years ago |
|